Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia — Stella

Home/Neonatal Hyperbilirubinemia/Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

View on ClinicalTrials.gov

Recruiting

Back to Neonatal Hyperbilirubinemia trials

Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Egypt

Neonatal Intensive Care Unit (NICU) of Ain Shams University Hospitals, Cairo, Cairo Governorate

Key details

Phase

Post-approval study

Sponsor

Amira Adel Fouly

Collaborators

Egyptian Chinese University, Ain Shams University

Enrollment target

~80 participants

Started

September 2024

Primary completion

June 2026

Age range

1 Day – 1 Month

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.